Systemic	0	8	O
regulation	9	19	O
of	20	22	O
distraction	23	34	O
osteogenesis	35	47	O
:	47	48	O
a	49	50	O
cascade	51	58	O
of	59	61	O
biochemical	62	73	O
factors	74	81	O
.	81	82	O

This	84	88	O
study	89	94	O
investigates	95	107	O
the	108	111	O
systemic	112	120	O
biochemical	121	132	O
regulation	133	143	O
of	144	146	O
fracture	147	155	O
healing	156	163	O
in	164	166	O
distraction	167	178	O
osteogenesis	179	191	O
compared	192	200	O
with	201	205	O
rigid	206	211	O
osteotomy	212	221	O
in	222	224	O
a	225	226	O
prospective	227	238	O
in	239	241	O
vivo	242	246	O
study	247	252	O
in	253	255	O
humans	256	262	B-Organism
.	262	263	O

To	264	266	O
further	267	274	O
clarify	275	282	O
the	283	286	O
influence	287	296	O
of	297	299	O
mechanical	300	310	O
strain	311	317	O
on	318	320	O
the	321	324	O
regulation	325	335	O
of	336	338	O
bone	339	343	B-Organ
formation	344	353	O
,	353	354	O
bone	355	359	B-Organ
growth	360	366	O
factors	367	374	O
(	375	376	O
insulin	376	383	B-Gene_or_gene_product
-	383	384	I-Gene_or_gene_product
like	384	388	I-Gene_or_gene_product
growth	389	395	I-Gene_or_gene_product
factor	396	402	I-Gene_or_gene_product
[	403	404	I-Gene_or_gene_product
IGF	404	407	I-Gene_or_gene_product
]	407	408	I-Gene_or_gene_product
I	409	410	I-Gene_or_gene_product
,	410	411	O
IGF	412	415	B-Gene_or_gene_product
binding	416	423	I-Gene_or_gene_product
protein	424	431	I-Gene_or_gene_product
[	432	433	I-Gene_or_gene_product
IGFBP	433	438	I-Gene_or_gene_product
]	438	439	I-Gene_or_gene_product
3	440	441	I-Gene_or_gene_product
,	441	442	O
transforming	443	455	B-Gene_or_gene_product
growth	456	462	I-Gene_or_gene_product
factor	463	469	I-Gene_or_gene_product
[	470	471	I-Gene_or_gene_product
TGF	471	474	I-Gene_or_gene_product
]	474	475	I-Gene_or_gene_product
beta1	476	481	I-Gene_or_gene_product
,	481	482	O
and	483	486	O
basic	487	492	B-Gene_or_gene_product
FGF	493	496	I-Gene_or_gene_product
[	497	498	O
bFGF	498	502	B-Gene_or_gene_product
]	502	503	O
)	503	504	O
,	504	505	O
bone	506	510	B-Cellular_component
matrix	511	517	I-Cellular_component
degrading	518	527	O
enzymes	528	535	O
(	536	537	O
matrix	537	543	B-Gene_or_gene_product
-	543	544	I-Gene_or_gene_product
metalloproteinases	544	562	I-Gene_or_gene_product
[	563	564	I-Gene_or_gene_product
MMPs	564	568	I-Gene_or_gene_product
]	568	569	I-Gene_or_gene_product
1	570	571	I-Gene_or_gene_product
,	571	572	O
2	573	574	B-Gene_or_gene_product
,	574	575	O
and	576	579	O
3	580	581	B-Gene_or_gene_product
)	581	582	O
,	582	583	O
human	584	589	B-Gene_or_gene_product
growth	590	596	I-Gene_or_gene_product
hormone	597	604	I-Gene_or_gene_product
(	605	606	O
hGH	606	609	B-Gene_or_gene_product
)	609	610	O
,	610	611	O
and	612	615	O
bone	616	620	B-Organ
formation	621	630	O
markers	631	638	O
(	639	640	O
ALP	640	643	B-Gene_or_gene_product
,	643	644	O
bone	645	649	B-Gene_or_gene_product
-	649	650	I-Gene_or_gene_product
specific	650	658	I-Gene_or_gene_product
ALP	659	662	I-Gene_or_gene_product
[	663	664	O
BAP	664	667	B-Gene_or_gene_product
]	667	668	O
,	668	669	O
and	670	673	O
osteocalcin	674	685	B-Gene_or_gene_product
[	686	687	O
OC	687	689	B-Gene_or_gene_product
]	689	690	O
)	690	691	O
have	692	696	O
been	697	701	O
analyzed	702	710	O
in	711	713	O
serum	714	719	B-Organism_substance
samples	720	727	I-Organism_substance
from	728	732	O
10	733	735	O
patients	736	744	B-Organism
in	745	747	O
each	748	752	O
group	753	758	O
pre	759	762	O
-	762	763	O
and	764	767	O
postoperatively	768	783	O
.	783	784	O

In	785	787	O
the	788	791	O
distraction	792	803	O
group	804	809	O
,	809	810	O
a	811	812	O
significant	813	824	O
postoperative	825	838	O
increase	839	847	O
in	848	850	O
MMP	851	854	B-Gene_or_gene_product
-	854	855	I-Gene_or_gene_product
1	855	856	I-Gene_or_gene_product
,	856	857	O
bFGF	858	862	B-Gene_or_gene_product
,	862	863	O
ALP	864	867	B-Gene_or_gene_product
,	867	868	O
and	869	872	O
BAP	873	876	B-Gene_or_gene_product
could	877	882	O
be	883	885	O
observed	886	894	O
during	895	901	O
the	902	905	O
lengthening	906	917	O
and	918	921	O
the	922	925	O
consolidation	926	939	O
period	940	946	O
when	947	951	O
compared	952	960	O
with	961	965	O
the	966	969	O
baseline	970	978	O
levels	979	985	O
.	985	986	O

Osteotomy	987	996	O
fracture	997	1005	O
healing	1006	1013	O
without	1014	1021	O
the	1022	1025	O
traction	1026	1034	O
stimulus	1035	1043	O
failed	1044	1050	O
to	1051	1053	O
induce	1054	1060	O
a	1061	1062	O
corresponding	1063	1076	O
increase	1077	1085	O
in	1086	1088	O
these	1089	1094	O
factors	1095	1102	O
.	1102	1103	O

In	1104	1106	O
addition	1107	1115	O
,	1115	1116	O
comparison	1117	1127	O
of	1128	1130	O
both	1131	1135	O
groups	1136	1142	O
revealed	1143	1151	O
a	1152	1153	O
significantly	1154	1167	O
higher	1168	1174	O
increase	1175	1183	O
in	1184	1186	O
TGF	1187	1190	B-Gene_or_gene_product
-	1190	1191	I-Gene_or_gene_product
beta1	1191	1196	I-Gene_or_gene_product
,	1196	1197	O
IGF	1198	1201	B-Gene_or_gene_product
-	1201	1202	I-Gene_or_gene_product
I	1202	1203	I-Gene_or_gene_product
,	1203	1204	O
IGFBP	1205	1210	B-Gene_or_gene_product
-	1210	1211	I-Gene_or_gene_product
3	1211	1212	I-Gene_or_gene_product
,	1212	1213	O
and	1214	1217	O
hGH	1218	1221	B-Gene_or_gene_product
in	1222	1224	O
the	1225	1228	O
lengthening	1229	1240	O
group	1241	1246	O
during	1247	1253	O
the	1254	1257	O
distraction	1258	1269	O
period	1270	1276	O
,	1276	1277	O
indicating	1278	1288	O
key	1289	1292	O
regulatory	1293	1303	O
functions	1304	1313	O
in	1314	1316	O
mechanotransduction	1317	1336	O
.	1336	1337	O

The	1338	1341	O
time	1342	1346	O
courses	1347	1354	O
of	1355	1357	O
changes	1358	1365	O
in	1366	1368	O
MMP	1369	1372	B-Gene_or_gene_product
-	1372	1373	I-Gene_or_gene_product
1	1373	1374	I-Gene_or_gene_product
,	1374	1375	O
bone	1376	1380	B-Organ
growth	1381	1387	O
factors	1388	1395	O
(	1396	1397	O
TGF	1397	1400	B-Gene_or_gene_product
-	1400	1401	I-Gene_or_gene_product
beta1	1401	1406	I-Gene_or_gene_product
and	1407	1410	O
bFGF	1411	1415	B-Gene_or_gene_product
)	1415	1416	O
,	1416	1417	O
and	1418	1421	O
hGH	1422	1425	B-Gene_or_gene_product
,	1425	1426	O
respectively	1427	1439	O
,	1439	1440	O
correlated	1441	1451	O
significantly	1452	1465	O
during	1466	1472	O
the	1473	1476	O
lengthening	1477	1488	O
phase	1489	1494	O
,	1494	1495	O
indicating	1496	1506	O
common	1507	1513	O
regulatory	1514	1524	O
pathways	1525	1533	O
for	1534	1537	O
these	1538	1543	O
factors	1544	1551	O
in	1552	1554	O
distraction	1555	1566	O
osteogenesis	1567	1579	O
.	1579	1580	O

Significant	1581	1592	O
correlation	1593	1604	O
between	1605	1612	O
the	1613	1616	O
osteoblastic	1617	1629	O
marker	1630	1636	O
BAP	1637	1640	B-Gene_or_gene_product
,	1640	1641	O
TGF	1642	1645	B-Gene_or_gene_product
-	1645	1646	I-Gene_or_gene_product
beta1	1646	1651	I-Gene_or_gene_product
,	1651	1652	O
and	1653	1656	O
bFGF	1657	1661	B-Gene_or_gene_product
suggests	1662	1670	O
strain	1671	1677	O
-	1677	1678	O
activated	1678	1687	O
osteoblastic	1688	1700	B-Cell
cells	1701	1706	I-Cell
as	1707	1709	O
a	1710	1711	O
major	1712	1717	O
source	1718	1724	O
of	1725	1727	O
systemically	1728	1740	O
increased	1741	1750	O
bone	1751	1755	B-Organ
growth	1756	1762	O
factors	1763	1770	O
during	1771	1777	O
callus	1778	1784	O
distraction	1785	1796	O
.	1796	1797	O

The	1798	1801	O
systemic	1802	1810	O
increase	1811	1819	O
in	1820	1822	O
bFGF	1823	1827	B-Gene_or_gene_product
and	1828	1831	O
MMP	1832	1835	B-Gene_or_gene_product
-	1835	1836	I-Gene_or_gene_product
1	1836	1837	I-Gene_or_gene_product
might	1838	1843	O
reflect	1844	1851	O
an	1852	1854	O
increased	1855	1864	O
local	1865	1870	O
stimulation	1871	1882	O
of	1883	1885	O
angiogenesis	1886	1898	O
during	1899	1905	O
distraction	1906	1917	O
osteogenesis	1918	1930	O
.	1930	1931	O

